Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:0A4J London Ordinary Share ASTRAZENECA ADR REPRESENTING 0.5 ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1,769 -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

AstraZeneca PLC Director/PDMR Shareholding

15/11/2021 4:00pm

UK Regulatory (RNS & others)

Astrazeneca (LSE:0A4J)
Historical Stock Chart

From Oct 2021 to Jan 2022

Click Here for more Astrazeneca Charts.


RNS Number : 4334S

AstraZeneca PLC

15 November 2021

15 November 2021 16:00 GMT

Transaction by Person Discharging Managerial Responsibilities

AstraZeneca PLC (the Company) announced that on 12 November 2021 an award of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company.

In accordance with the Agreement and Plan of Merger, the award was granted under the AstraZeneca Global Restricted Stock Plan at the time of closing of the acquisition of Alexion Pharmaceuticals, Inc. (Alexion) by the Company. It replaced Restricted Stock Units held by Dr Sarin under the Alexion 2017 Incentive Plan, granted in November 2017. The replacement award vested on the completion of the original four-year holding period.

Following the withholding of shares to satisfy certain tax obligations arising on vesting, 5,108 ADSs vested.

For tax purposes, the fair market value of an ADS at vest of the award was US$62.92, being the closing price on the last trading day preceding the vesting.

Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018.

 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                        Aradhana Sarin 
     --------------------------  ----------------------------------------- 
 2    Reason for the notification 
 a)   Position/status             Chief Financial Officer 
     --------------------------  ----------------------------------------- 
 b)   Initial notification        Initial notification 
     --------------------------  ----------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                        AstraZeneca PLC 
     --------------------------  ----------------------------------------- 
 b)   LEI                         PY6ZZQWO2IZFZC3IOL08 
     --------------------------  ----------------------------------------- 
 4i   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
 a)   Description of the          AstraZeneca PLC American Depositary 
       financial instrument,       Shares 
       type of instrument 
       Identification code         CUSIP: 046353108 
     --------------------------  ----------------------------------------- 
 b)   Nature of the transaction   Acquisition of AstraZeneca PLC American 
                                   Depository Shares pursuant to a vesting 
                                   under the Global Restricted Stock 
     --------------------------  ----------------------------------------- 
 c)   Price(s) and volume(s)        Price(s)   Volume(s) 
                                     0          5,108 
     --------------------------  ----------------------------------------- 
 d)   Aggregated information      Not applicable - single transaction 
       - Aggregated volume 
       - Price 
     --------------------------  ----------------------------------------- 
 e)   Date of the transaction     12 November 2021 
     --------------------------  ----------------------------------------- 
 f)   Place of the transaction    Outside a trading venue 
     --------------------------  ----------------------------------------- 


AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.


For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

Adrian Kemp

Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

November 15, 2021 11:00 ET (16:00 GMT)

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220128 05:44:47